Your browser doesn't support javascript.
loading
Recurrence and disease-free survival outcomes after computed tomography-guided needle biopsy in stage IA non-small cell lung cancer patients in China: a propensity score matching analysis.
He, Chuang; Yu, Hualong; Li, Changyi; Zhang, Xin; Huang, Zhicheng; Liu, Mingyang; Tong, Lunbing; Zhu, Jun; Wu, Wei; Huang, Xuequan.
Afiliação
  • He C; Treatment Center of Minimally Invasive Intervention and Radioactive Particles, First Affiliated Hospital of the Army Medical University, Chongqing, China.
  • Yu H; Department of Radiology, Affiliated Hospital of Qingdao University, Qingdao, China.
  • Li C; Department of Respiratory, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  • Zhang X; Department of Thoracic Surgery, General Hospital of Heilongjiang Province Land Reclamation Bureau, Harbin, China.
  • Huang Z; Department of Radiology, Jilin Provincial Cancer Hospital, Changchun, China.
  • Liu M; Department of Oncology, General Hospital of Heilongjiang Province Land Reclamation Bureau, Harbin, China.
  • Tong L; Department of Radiology, Sichuan Police Force Hospital, Leshan, China.
  • Zhu J; Department of Radiology, The Second People's Hospital of Yibin, Yibin, China.
  • Wu W; Department of Thoracic Surgery, First Affiliated Hospital of the Army Medical University, Chongqing, China.
  • Huang X; Treatment Center of Minimally Invasive Intervention and Radioactive Particles, First Affiliated Hospital of the Army Medical University, Chongqing, China.
Quant Imaging Med Surg ; 11(8): 3472-3480, 2021 Aug.
Article em En | MEDLINE | ID: mdl-34341724
BACKGROUND: Whether preoperative biopsy before radical resection can lead to recurrence and impact patient survival in non-small cell lung cancer (NSCLC) remains controversial. In this study, we carried out a retrospective analysis to determine whether preoperative biopsy can cause disease recurrence and influence disease-free survival (DFS) in patients with stage IA NSCLC. METHODS: Patients diagnosed with stage IA NSCLC (solid nodule) between January 2010 and December 2014 were identified from the databases of 7 Chinese medical centers and divided into two groups: a preoperative computed tomography (CT)-guided needle biopsy (CTNB) plus radical resection group, and a non-CTNB group. The propensity score matching (PSM) method was adopted to balance the observed covariates, and Kaplan-Meier estimates were used for survival analysis. Cox regression was used in a single-factor analysis to identify the factors affecting DFS in stage IA NSCLC. RESULTS: After initial screening, 730 patients were enrolled in this study, with 186 and 544 patients in the CTNB group and the non-CTNB group, respectively. After PSM, 186 patients were eventually included in each group. No significant differences in basic clinical features were identified between the two groups (P>0.05). The rates of recurrence were 17.2% and 14.0% in the CTNB and non-CTNB groups (χ2=0.735, P=0.391), respectively. No notable differences in DFS (χ2=1.895, P=0.173) or overall survival (OS, χ2=1.785, P=0.182) were observed. Lung adenocarcinoma [hazard ratio (HR), 0.167, P=0.001] and lesion size (>2 cm) (HR, 2.712, P=0.000) were identified as risk factors for DFS in stage IA NSCLC. CONCLUSIONS: CTNB does not increase the incidence of recurrence in stage IA NSCLC or affect patient survival; therefore, it is not a risk factor for DFS. Lung adenocarcinoma and lesion size are risk factors for DFS.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Pulmao Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Quant Imaging Med Surg Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Pulmao Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Quant Imaging Med Surg Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China